B. Riley Wealth Advisors Inc. Lowers Stock Position in Haleon plc (NYSE:HLN)

B. Riley Wealth Advisors Inc. reduced its position in Haleon plc (NYSE:HLN) by 18.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 23,805 shares of the company’s stock after selling 5,519 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Haleon were worth $196,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HLN. Sivia Capital Partners LLC acquired a new stake in Haleon during the fourth quarter worth about $93,000. SageView Advisory Group LLC acquired a new stake in Haleon during the 4th quarter worth approximately $100,000. Wellington Management Group LLP raised its holdings in Haleon by 164.6% in the fourth quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock valued at $111,454,000 after buying an additional 8,423,475 shares during the period. Goldman Sachs Group Inc. lifted its position in Haleon by 19.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,813,997 shares of the company’s stock valued at $39,619,000 after buying an additional 772,829 shares in the last quarter. Finally, Syon Capital LLC grew its stake in Haleon by 31.4% during the fourth quarter. Syon Capital LLC now owns 67,711 shares of the company’s stock worth $557,000 after buying an additional 16,175 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Price Performance

HLN opened at $8.27 on Friday. The company has a fifty day simple moving average of $8.41 and a 200 day simple moving average of $8.34. The firm has a market cap of $37.76 billion, a price-to-earnings ratio of 27.57, a PEG ratio of 2.26 and a beta of 0.26. Haleon plc has a twelve month low of $7.70 and a twelve month high of $8.96. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53.

Haleon (NYSE:HLN) last posted its quarterly earnings data on Wednesday, May 1st. The company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.01. Haleon had a net margin of 9.68% and a return on equity of 13.17%. The firm had revenue of $3.70 billion for the quarter, compared to the consensus estimate of $3.71 billion. Equities research analysts expect that Haleon plc will post 0.46 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on HLN. Berenberg Bank began coverage on shares of Haleon in a research report on Wednesday, June 5th. They issued a “buy” rating for the company. Argus reissued a “buy” rating on shares of Haleon in a research report on Tuesday, March 26th. Finally, HSBC started coverage on shares of Haleon in a report on Wednesday, April 17th. They set a “buy” rating for the company. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy”.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.